1. A pilot randomized clinical trial of γ-tocopherol supplementation on wood smoke–induced neutrophilic and eosinophilic airway inflammation
- Author
-
David B. Peden, MD, Martha Almond, RRT, Christian Brooks, BS, Carole Robinette, MS, Heather Wells, MS, Allison Burbank, MD, Michelle Hernandez, MD, Alan Hinderliter, MD, Melissa Caughey, PhD, Qing Jiang, PhD, Qianyue Wang, MS, Haolin Li, BSPH, Haibo Zhou, PhD, and Neil Alexis, PhD
- Subjects
γ-Tocopherol ,wood smoke particles ,air pollution ,eosinophils ,neutrophils ,asthma ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Background: Air pollutants, including particulates from wood smoke, are a significant cause of exacerbation of lung disease. γ-Tocopherol is an anti-inflammatory isoform of vitamin E that has been shown to reduce allergen-, ozone-, and endotoxin-induced inflammation. Objective: The objective of this study was to determine whether γ-tocopherol would prevent experimental wood smoke–induced airway inflammation in humans. Methods: This was a randomized, placebo-controlled clinical trial testing the effect of a short course of γ-tocopherol–enriched supplementation on airway inflammation following a controlled exposure to wood smoke particulates. Results: Short-course γ-tocopherol intervention did not reduce wood smoke–induced neutrophilic airway inflammation, but it did prevent wood smoke–induced eosinophilic airway inflammation. Conclusion: γ-Tocopherol is a potential intervention for exacerbation of allergic airway inflammation, but further study examining longer dosing periods is required.
- Published
- 2023
- Full Text
- View/download PDF